Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes

Toxicology

Volumn 218, Issue 2-3, 2006, Pages 90-99

  Khan, Farah D ^a,b   Roychowdhury, Sanjoy ^b   Nemes, Radita ^a   Vyas, Piyush M ^a,b   Woster, Patrick M ^a   Svensson, Craig K ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Cutaneous drug reactions; Cytokines; Cytotoxicity; Glutathione; Keratinocytes; Sulphonamides

Indexed keywords

AMINE; ARYLHYDROXYLAMINE; CYTOKINE; DAPSONE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SULFAMETHOXAZOLE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADDUCTION; ARTICLE; CELL STIMULATION; CYTOTOXICITY; EPIDERMIS CELL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; KERATINOCYTE; MONOCYTE; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CELL DEATH; CELLS, CULTURED; DAPSONE; GLUTATHIONE; HUMANS; HYDROXYLAMINES; INTERFERON TYPE II; INTERLEUKIN-1; KERATINOCYTES; LIPOPOLYSACCHARIDES; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SULFAMETHOXAZOLE; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 29244443242     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.10.002     Document Type: Article

References (40)

1. M.E. Anderson Glutathione and glutathione delivery compounds Adv. Pharmacol. 38 1997 65 78
2. N. Bachot, and J.C. Roujeau Differential diagnosis of severe cutaneous drug eruptions Am. J. Clin. Dermatol. 4 2003 561 572
3. A.M. Barbaud, M.C. Bene, and G. Fagure Immunological physiopathology of cutaneous adverse drug reactions Eur. J. Dermatol. 7 1997 319 323
4. M. Bigby, S. Jick, H. Jick, and K. Arndt Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975-1982 JAMA 256 1982 3358 3363
5. A. Carr, B. Tindall, R. Penny, and D.A. Cooper In vitro cytotoxicity as a marker of hypersensitivity to sulfamethoxazole in patients with HIV Clin. Exp. Immunol. 94 1993 21 25
6. A.E. Cribb, T. McQuaid, and K.W. Renton Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat Biochem. Pharmacol. 62 2001 457 459
7. A.E. Cribb, S.P. Spielberg, and G.P. Griffin N4-Hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P450 2C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes Drug Metab. Dispos. 23 1995 406 414
8. P.S. Friedmann, M.S. Lee, A.C. Friedmann, and R.S. Barnetson Mechanisms in cutaneous drug hypersensitivity reactions Clin. Exp. Allergy 33 2003 861 872
9. C. Goebel, C. Vogel, M. Wulferink, S. Mittmann, B. Sachs, S. Schraa, J. Abel, G. Degen, J. Uetrecht, and E. Gleichmann Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages Chem. Res. Toxicol. 12 1999 488 500
10. R. Guy, and T. Kealey The effects of inflammatory cytokines on the isolated human sebaceous infundibulum J. Invest. Dermatol. 110 1998 410 415
11. E.R. Kandimalla, L. Bhagat, F.-G. Zhu, D. Yu, Y.-P. Cong, D. Wang, J.X. Tang, J.-Y. Tang, C.F. Knetter, E. Lien, and S. Agrawal A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif PNAS 100 2003 14303 14308
12. M. Kuppner, R. Gelwer, S. Nossner, E. Ochmann, O. Scharner, and R. AIssels The role of heat shock protein (hsp70) in dendritic cell maturation Eur. J. Dermatol. 31 2001 1602 1609
13. A. la Sala, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni Alerting and tuning the immune response by extracellular nucleotides J. Leukoc. Biol. 73 2003 339 343
14. J. Lazarou, B.H. Pomeranz, and P.N. Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1998 1200 1205
15. L. Liu, A.A. Roberts, and T. Ganz By IL-1 signalling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide J. Immunol. 170 2003 575 580
16. J.A. Maier, T. Hla, and T. Maciag Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells J. Biol. Chem. 265 1990 10805 10808
17. H. Matsuura, M. Sakaue, K. Subbaramaiah, H. Kamitani, T.E. Eling, A.J. Dannenberg, T. Tanabe, H. Inoue, J. Arata, and A.M. Jetten Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases J. Biol. Chem. 274 1999 29138 29148
18. E.T. Morgan Regulation of cytochromes P450 during inflammation and infection Drug Metab. Rev. 29 1997 1129 1188
19. D.J. Naisbitt, M. Pirmohamed, and B.K. Park Immunopharmacology of hypersensitivity reactions to drugs Curr. Allergy Asthma Rep. 3 2003 22 29
20. L. Naldi, A. Conforti, M. Venegoni, T.M. Grazia, A. Caputi, E. Ghiotto, A. Cocci, U. Moretti, G. Velo, and R. Leone Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions Br. J. Clin. Pharmacol. 48 1999 839 846
21. B.J. Nickoloff, and L.A. Turka Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes Immunol. Today 15 1994 464 469
22. W.M. O'Neil, R.K. Drobitch, R.D. MacArthur, M.J. Farrough, M.A. Doll, A.J. Fretland, D.W. Hein, L.R. Crane, and C.K. Svensson Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype Pharmacogenetics 10 2000 171 182
23. M. Pirmohamed, A. Alfirevic, J. Vilar, A. Stalford, E. Wilkins, E. Sim, and B. Park Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity Pharmacogenetics 10 2000 705 713
24. M. Pirmohamed, A.M. Breckenridge, N.R. Kitteringham, and B.K. Park Fortnightly review: adverse drug reactions Br. Med. J. 316 1998 1295 1298
25. M.J. Reider, J. Uetrecht, N.H. Shear, M. Cannon, M. Miller, and S.P. Spielberg Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites Ann. Intern. Med. 110 1989 286 289
26. T.P. Reilly, L.H. Lash, M.A. Doll, D.W. Hein, P.M. Woster, and C.K. Svensson A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions J. Invest. Dermatol. 114 2000 1164
27. M.J. Rieder, J. Uetretcht, N.H. Shear, and S.P. Spielberg Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides J. Pharmacol. Exp. Ther. 244 1988 724 728
28. S. Roychowdhury, P.M. Vyas, T.P. Reilly, A.A. Gaspari, and C.K. Svensson Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes J. Pharmacol. Exp. Ther. 314 2005 43 52
29. R.L. Rubin, and J.T. Curnutte Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro J. Clin. Invest. 83 1989 1336 1343
30. Y. Shi, E.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
31. I. Singh, K. Pahan, M. Khan, and A.K. Singh Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating disease J. Biol. Chem. 273 1998 20354 20362
32. F.J. Staal, M. Roederer, D.M. Israelski, J. Bubp, L.A. Mole, D. McShane, S.C. Deresinski, W. Ross, H. Sussman, P.A. Raju, M.T. Anderson, W. Moore, S.W. Ela, and L.A. Herzenberg Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals AIDS Res. Hum. Retroviruses 8 1992 305 311
33. C.K. Svensson Do arylhydroxylamine metabolites mediate idiosyncratic reactions associated with sulfonamide? Chem. Res. Toxicol. 16 2003 1035 1043
34. C.K. Svensson, E.W. Cowen, and A.A. Gaspari Cutaneous drug reactions Pharmacol. Rev. 53 2001 357
35. J.P. Uetrecht The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions Drug Metab. Rev. 24 1992 299 366
36. C. Vage, and C.K. Svensson Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1 Drug Metab. Dispos. 22 1994 572 577
37. P.M. Vyas, S. Roychowdhury, P.M. Woster, and C.K. Svensson Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes Biochem. Pharmacol. 70 2005 275 286
38. H. Wakita, K. Nishimura, Y. Tokura, F. Furukawa, and M. Takigawa Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma J. Invest. Dermatol. 107 1996 336 342
39. S.L. Walmsley, L.M. Winn, M.L. Harrison, J.P. Uetrecht, and P.G. Wells Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications AIDS 11 1997 1689 1697
40. C.P. Yao, G.G. Mather, J.R. Stephens, and R.H. Levy Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndrome Biochem. Pharmacol. 58 1999 455 459